Search Results 611-620 of 17928 for Assay

  1. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  2. Clinical Trials - M6620 First in Human Study

    Subjects who are documented to be non-basaloid subtype using molecular profiling assay (e.g. PAM50 assay) prior to Screening; Subjects with unknown BRCA1 ...

  3. Living-Donor Kidney Transplant Clinical Trials - Mayo Clinic Research

    The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney transplant recipients ...

  4. Letrozole in Treating Postmenopausal Women with Ductal Carcinoma in Situ - Mayo Clinic

    Age < 55 years and one year or more amenorrhea, with an estradiol assay < 20pg/ml; Surgical menopause with bilateral oophorectomy (at least 28 days must ...

  5. Lumbar Puncture (Spinal Tap) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to validate the Alzheimer Disease Biomarkers assays (Phospho-Tau/Total-Tau/Ab42) being implemented at Mayo to compare them to the ...

  6. A Study to Evaluate Molecular and Biochemical Testing for Suspected Hereditary Disorders - Mayo Clinic

    ... assay such as methylation-sensitive MLPA; borderline droplet count or copy number detected by ddPCR or qPCR, respectively;; A single mutation identified in a ...

  7. A Study to Evaluate Radiation Therapy, Plasma Exchange, and Immunotherapy in Melanoma - Mayo Clinic

    ... assay (ELISA) - Feasible vascular access as determined by study apheresis technician (either by peripheral intravenous access or by placement of a temporary ...

  8. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  9. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  10. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology-directed repair (HDR) functional assay.